APA (7th ed.) Citation

AN, A., MS, A., F, O., AM, M., EM, E., SSA, M., . . . AA, E. (2026). Nano-Diosmin mitigates EAC-induced renal injury through Nrf2-mediated antioxidant activation and NF-κB-dependent apoptotic suppression. Medical oncology (Northwood, London, England), 43(11), . https://doi.org/10.1007/s12032-026-03387-3

Chicago Style (17th ed.) Citation

AN, Alshammari, Alfawaz MS, Oraby F, Mohamed AM, Elmorsy EM, Mohamed SSA, Atta MMF, and El-Raghi AA. "Nano-Diosmin Mitigates EAC-induced Renal Injury Through Nrf2-mediated Antioxidant Activation and NF-κB-dependent Apoptotic Suppression." Medical Oncology (Northwood, London, England) 43, no. 11 (2026). https://doi.org/10.1007/s12032-026-03387-3.

MLA (9th ed.) Citation

AN, Alshammari, et al. "Nano-Diosmin Mitigates EAC-induced Renal Injury Through Nrf2-mediated Antioxidant Activation and NF-κB-dependent Apoptotic Suppression." Medical Oncology (Northwood, London, England), vol. 43, no. 11, 2026, https://doi.org/10.1007/s12032-026-03387-3.